AzTrials
AzTrials

Sleep Disordered Breathing (SDB)QualSDB_CPNCT06753370

Experiences of Managing Sleep Disordered Breathing in Children With Cerebral Palsy.

An observational study of Sleep Disordered Breathing (SDB) and Cerebral Palsy (CP), run by University of Edinburgh at 2 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cerebral palsy (CP) refers to a non-progressive movement disorder, which occurs due to damage to the developing brain around the time of birth. Symptoms of sleep disordered breathing (SDB) include noisy breathing during sleep, increased day-time sleepiness and reduced energy levels. Read more about this study

Who is it for?
Ages 1 month to 16 years
How many people
24 participants
Where
2 sitesUnited Kingdom
Study dates
28 Feb 2025to 1 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children and young people with cerebral palsy who are (or have been) managed with respiratory support for sleep disordered breathing, their parents/carer and health professionals involved in their care.

Who may be able to join

  • Children and young people with CP and SDB;
  • Children and young people aged less than (but not including) 16 years old
  • Formal diagnosis of Cerebral Palsy
  • Formal diagnosis of Sleep Disordered Breathing (currently or previously managed with respiratory support)
  • Able to understand, communicate (with or without aids) and engage with interview (guided by parents/carer opinion on capacity to engage in interview)
  • Parents/carers of CYP with CP;
Show all 9Show fewer
  • Parents/carer of CYP with CP and SDB being (or has been) managed with respiratory support
  • Health care professional;
  • Professionals (based in community or hospital setting) involved in the management of SDB in CYP with CP

Who cannot join

  • Children and young people with CP and SDB and their parents/carers;
  • CYP with CP on respiratory support for failure to wean as neonate or for Chronic Lung Disease
  • CYP on respiratory support for other neuromuscular or neurodisability conditions
  • Health care professional; Nil

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • NHS Lothian

    Edinburgh, Edinbrugh, EH16 4TJ

  • Department of Paediatric Respiratory and Sleep Medicine, Royal Hospital for Children and Young People

    Edinburgh, Merseyside, EH16 4TJ

Other trials in United Kingdom

About this study

Official title: Experiences of Children and Young People (CYP) With Cerebral Palsy (CP), Their Parents/Caregivers and Healthcare Professionals in Managing Sleep Disordered Breathing (SDB).

Cerebral palsy (CP) refers to a non-progressive movement disorder, which occurs due to damage to the developing brain around the time of birth. Symptoms of sleep disordered breathing (SDB) include noisy breathing during sleep, increased day-time sleepiness and reduced energy levels. In the long term, SDB might have an effect on the brain and learning, as well as putting strain on the heart.

Children with CP have a higher risk of sleep breathing problems compared to typically-developing children. The negative impact of sleep disturbance in children with CP, on their family members/carers' sleep and mental health cannot be understated. Early recognition and management of SDB is important for children with CP to give these children the best possible sleep quality, and to maximise learning potential.

Read more

SDB in children with CP is often under-recognised and under-treated. Treatment of SDB in children with CP might involve wearing a mask that delivers pressurised air to hold open a child's airway and make breathing easier when they are asleep. This is called 'respiratory support' which can be continuous pressure (CPAP) or non-invasive ventilation (NIV) which is pressure support with a back-up breathing rate. There is limited knowledge on the appropriate indications or timing to use them. Though respiratory support in children with CP is proven to help with breathing during sleep, its impact on quality of life, number of hospital admissions or frequency of chest infections is unknown.

This study will analyse the experiences of children with CP being managed for SDB, and the views of their carers/parents, and health professionals involved in their care. By undertaking semi-structured interviews, the investigators aim to explore the impact SDB and it's management has on children

Read the detailed description

The journey and experience of children with CP being managed for SDB can be unique and varied. Hence a qualitive semi-structed interview will offer the best insight into their journey and learn ways to improve the experiences for other children in the future.

The investigators aim to interview;

  • Children with CP aged <16 years old, and able to participate in the interview. No lower age limit is defined, as children with CP can have potential underlying learning disability and chronological lower limit age cut off will not be useful in defining ability to engage with study. Instead, each child will be looked at individually with input from parents/carer to determine ability to engage with study.
  • Parents/carers of children with CP. There may be times where only the parent/carer is being interviewed as the child is not able to (or does not wish to) engage with the interview. Where both the child with CP and parent/carer are being interviewed, this will be done concurrently.
  • Healthcare professionals involved in the management of children with CP and being (or has been) managed with respiratory support for sleep disordered breathing.

The investigators aim to interview 10 children with CP and/or their parents/carer and 10 health professionals, or till no new themes emerge.

The participants for the interview will be identified by the members of the sleep/LTV team and/or by disseminating the study on charity sites and professional membership groups for suitable individuals to contact the research team to express interest.

Those who have confirmed participation in the study will be invited for a single interview either in person or online. Written consent (on paper copy or online) will be gained before the interview. The interview will be conducted as per the relevant interview schedule for children with CP, parents/carers and health professionals. Relevant additional information about the participant will also be documented in the field notes at time of interview.

Keywords
sleep disordered breathing, cerebral palsy, respiratory support, qualitative research
Medical subject headings
Sleep Apnea Syndromes, Cerebral Palsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Themes describing experiences of assessment and management of sleep disordered breathing in children and young people with CP

    Themes describing the experience of children and young people (CYP) with CP in the assessment and management (with respiratory support) of SDB. Emerging themes will be identified through matrix analysis of semi-structured interview (with a phenomenology methodology).

    Measured: From enrolment till end of study at 6 months

  2. Themes describing experiences of assessment and management of sleep disordered breathing in family members and carers of children with CP.

    Themes describing the experience of family member/carer in the assessment and management (with respiratory support) of SDB in CYP with CP. Emerging themes will be identified through matrix analysis of semi-structured interview (with a phenomenology methodology).

    Measured: From enrollment till end of study at 6 months

  3. Themes describing experiences of assessment and management of sleep disordered breathing in healthcare professionals of children with CP.

    Themes describing the experience of healthcare professionals in the assessment and management (with respiratory support) of SDB in CYP with CP. Emerging themes will be identified through matrix analysis of semi-structured interview (with a phenomenology methodology).

    Measured: From enrolment till end of study at 6 months

Secondary outcomes (3)
  1. Facilitators of establishing respiratory support

    Factors which facilitate initiation and establishing respiratory support for SDB in CYP with CP will be identified through matrix analysis of semi-structured interviews for emerging themes (with a phenomenology methodology).

    Measured: From enrollment till end of study at 6 months

  2. Barriers to establishing respiratory support

    Factors which act as barriers to setting up and establishing respiratory support for SDB in CYP with CP will be identified through matrix analysis of semi-structured interviews for emerging themes (with a phenomenology methodology).

    Measured: From enrollment till end of study at 6 months

  3. Accessibility to sleep services

    Strategies to improve accessibility to sleep services for managing SDB in CYP with CP will be identified through matrix analysis of semi-structured interviews for emerging themes (with a phenomenology methodology).

    Measured: From enrollment till end of study at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2024
  2. Study start28 Feb 2025
  3. Primary completion31 May 2026
  4. Study completion1 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06753370
Sponsor's protocol ID
AC24190
Acronym
QualSDB_CP
Status last verified
Jun 2026
First submitted
9 Dec 2024
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Disordered Breathing (SDB) and Cerebral Palsy (CP), run by University of Edinburgh at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Themes describing experiences of assessment and management of sleep disordered breathing in children and young people with CP (time frame: From enrolment till end of study at 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in